Information Library

Results for: Enrollment & retention - Clinical Services - Product Development & Commercialization

In the complex environment of the New Health, Quintiles is committed to helping you succeed. At every stage of your product’s lifecycle, we are dedicated to delivering real results, being proactive in navigating issues and thinking of new solutions.  Search our library today.

Start Over

  • Sort by:
  • Recently Added
  • Title

  • Deploying Clinical Trial Educators to Increase Clinical Trial Recruitment

    Hear from the Experts — February 1, 2011
    In the February 2011 issue of the ACRP Monitor experts from Quintiles explain the importance of Clinical Trial Educators (CTEs) and their role in clinical

  • QUINTILES AND KAISER PERMANENTE ANNOUNCE ALLIANCE TO ACCELERATE DRUG DEVELOPMENT

    Press Release — May 18, 2010 - Quintiles is accelerating drug development with the addition of Kaiser Permanente's Southern California Permanente Medical Group to its global site program

  • Regulatory Landscapes for Future Antidiabetic Drug Development

    Hear from the Experts — May 12, 2010
    In the March 2010 Journal for Clinical Studies, Dr. Erica Caveney and Dr. Rick Turner analyze the EMA Guidance on diabetes drugs and cardiovascular risk.

  • FDA Requirements for Clinical Studies in Pediatric Patients

    White Paper — April 1, 2010
    FDA Requirements for Clinical Studies in Pediatric Patients FDA rules around pediatric drug trials have been tightening, to ensure more targeted data on drug efficacy

  • Propelling Pediatric Research

    Case Study — April 1, 2010
    Learn how Quintiles' global reach and rigorous research standards dramatically cut recruitment from 4 years to 1 in a childhood immunology study

  • Boosting Pediatric Enrollment

    Case Study — April 1, 2010
    Read how Quintiles took a nasal influenza vaccine trial from the brink of delay to full recruitment in only two weeks.

  • Anticipating the Challenge

    Case Study — March 3, 2010
    Extensive experience and expertise in Alzheimer's Disease accelerated outcomes in multi-country Phase II study.

  • Advancing Innovation

    Case Study — March 3, 2010
    Prescreening and safety measures simplified a Phase II study of a four-dose vaccine that required multiple rating scales.

  • Alzheimer's Inroads

    Case Study — March 3, 2010
    A global, multi-site Phase III trial required a large number of patients with a specific number of sites and patients at each site.

  • Trumping Expectations

    Case Study — March 1, 2010
    Quintiles sails past recruitment hurdles with tailored approaches that build momentum

Page 1 of 2 (12 results)

Subscribe to Email Based on Your Interests

Set preferences